Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
i suspect nasdaq will not like this... no ipo, cant trade on nasdaq... hope I am wrong...fingers crossed
lolmcshizz.. I cant lie and say I am not concerned about this...with whimax on this but to be honest dont really understand the process well...may need to email him afterall...wish i didnt miss the phone in last night but had family commitments..if there is no ipo then mm will decide value as per Roker. they will choose the figure that has been taken off tils...I am not sure if i want tils to rise now or drop... if they had given an ipo value then surely tils would have risen and dropped by same amount... now it seems we are in limo... hope someone will tell me I am completely off the mark...
There is still some time between now and Accustem listing so a lot can happen between now and then. I also seen the detail in 16 September rns...and hence I mentioned ipo in my earlier post today. I assume some form of valuation will be put forward before listing followed by an ipo which would imo be a good way to get stem out in q1 but also provide shareholders with some value.
Maybe Shiraz can send another email to the good Doctor in order to clarify :)
Hi again.
The inconsistency between the RNS and the Circular needs to be clarified - Accustem is going to need a good deal of funding to bring StemPrintER so I expect the board to announce a fund-raising along with the Admission. As I said, sloppy and confusing drafting.
Thank you Roker, that’s exactly my understanding. JH up to usual tricks of shouting people down, telling them they are wrong, but providing zero insight.
This is not an IPO (as such), it is a listing. It can only be an IPO if StemPrinter is valued before it lists and as far as I can see there is no intention to do that. . It has been attributed £4m as a nominal value from TILS (as per HMRC clearance).
Hi Whimax
According to my reading of the Demerger Shareholder CIrcular, as per my post the other day, there is no reference to an Initial Public Offering in that document although the RNS dated 16 September does include a reference to an Initial Public Offering which is inconsistent and sloppy drafting by the board and its advisers.
The Demerger Shareholder Circular refers to the Accustem Admission as a defined term which I quoted verbatim in my earlier post. An Admission to the London Stock Exchange means shares can be traded, but the price will be set on the first day of Admission by market makers and the market. There won't be a pre-set price for trading unless new money is raised at the same time, which would make it an Initial Public Offering. The board may be planning an Initial Public Offering (which would be an offer of new stock in Accustem to new shareholders) after the Admission has occurred, but the Demerger Shareholder CIrcular we voted on does not say that.
If people want to understand how Admissions work, they should have a look at the relevant pages of the London Stock Exchange website.
Try looking at some company that have Recently demerge and listed the business from within the company.
Come on Whimax are you that naive to how an IPO works. I suggest some research.
As I’m not going to explain it to you.
As far as we know, Investors are not getting the opportunity to “tell the company how much they will invest” do we? As far as we know there will be same number of shares issued into AccuStem as there are in TILS, i.e. shares will be issued on 1 for 1 basis. There has been no mention of raising funds (in fact quite the opposite if what Has been posted about last nights call is anything to go by).
In order for “this to be priced” someone will need to put a valuation on it, and that hasn’t happened, has it?
Sorry Whimax but what a load of twaddle you’ve just posted.
whimax an IPO is an initial public offering, so investors tell the company how much they will invest, and some shares are allotted to each person, (its more more in depth)
Whimax how did you think any private company that seeks a public listing is priced ?
I thought you would be somewhat wiser on the subject.
I didn’t listen to Conf Call last night but I think some are getting confused here imo.
When people to refer to “the” IPO to what are they referring? JH you said “ Funding for Accustem will be raised through the IPO”. How can they raise money if there is no valuation of StemPrinter? They can’t!!
We have been told that AccuStem will provide shares on a 1 for 1 basis to those who hold shares in TILS at the cut off date. If they wish to raise money for future development of StemPrinter/AccuStem they will have to wait until it is listed, has “found It’s level“ (which will be decided by the market) and then do a placing. Based on what we know, there is no other way of doing it.
It is intended that Accustem will seek admission to the standard segment of the Official List and admission to trading on the London Stock Exchange plc by way of an IPO in late Q4 2020 ("Accustem Admission") and potentially a dual listing on NASDAQ in 2021.
JH IPO would be the best way to do it
Funding for Accustem will be raised through the IPO
alam, am sure funding for Accustem will be needed, but we know that in Q1 they will start in Milan Cancer institute with Stem, not a bad place to start.
Lolm....if there is no quick sale planned they will need funds to secure ce mark and also to launch stem in q1?
Bmo3 ...not much to be said about the American investors....lolm thanks for clarifying....accustem funding...I would assume they would need funding for Accustem unless there are other plans such as a sale already agreed.
I also feel that he was indicating another valuation coming our way - after the split, I can't remember specifically what he said but he sounded fairly confident that it would be valued appropriately. He really shut down the idea of a quick sale, essentially saying "why would they do that" when it'll be worth so much more than the competition that just sold for $2.8 billion.
I also particularly loved his rationale behind why they are confident with the Crohns treatment and how ridiculous it is that you would treat through IV and shock the whole body when it's inflammation of the gut and therefore you treat the gut. Made it sound so simple.
alam what are you going on about that yank said the company was broke.......and this is why the world is broke that if someone can write something everyone thinks its fact, the poor Dr was like what are you going on about we have 57 million, and the fact that the company could have raised more fund but didnt....well it says it all.
He confirmed that there were no plans to fund raise for Accumstem initially - although I feel he was slightly backed into a corner on that one, I'm not entirely convinced as £4M in the bank isn't likely to get them very far... is it?
shiraz, accustem he doesnt know the value of it he said when it joins the Main Market and NOT AIM, and that the BOD wanted the split as Tils has its own products, and Stem is a totally different thing. He also said that the Covid trial should start in the first week of November and results by end of year, the the SP of Tils i am thinking will not tank after the split, and i think it been done this way for shareholder value
Shiraz I thought he said no fund raise for Tils....I assume there will have to be some form of raise for Accustem? They could do a ipo on launch on top of allotted shares?